{"id":913958,"date":"2025-11-26T07:06:43","date_gmt":"2025-11-26T12:06:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/"},"modified":"2025-11-26T07:06:43","modified_gmt":"2025-11-26T12:06:43","slug":"arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/","title":{"rendered":"Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEW HAVEN, Conn., Nov.  26, 2025  (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Noah Berkowitz, M.D., Ph.D., Chief Medical Officer, and Andrew Saik, Chief Financial Officer, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4 at 11:00 a.m. ET in New York.<\/p>\n<p align=\"left\">A live audio webcast of the presentation will be available\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=acdggAWnkTFn49qo29M1GP_n3ANWnFX2nnMBPLKbxowSmsICRMslDD-C0sX7guKWdzl7sTb8r7np908ZRQQ9GGg-VWEWgo7fJsipFB63CysyXHQiArEiMbfco31vWKXIt22eZ0dpWqNVwJ0hoG2nGw==\" rel=\"nofollow\" target=\"_blank\"><strong>here<\/strong><\/a>\u00a0and on the Events and Presentations section of the Company\u2019s website.<\/p>\n<p align=\"left\">\n        <strong>About\u00a0Arvinas<\/strong>\n      <\/p>\n<p align=\"left\">Arvinas (Nasdaq: ARVN) is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. Through its PROTAC (PROteolysis TArgeting Chimera) protein degrader platform, Arvinas is pioneering the development of protein degradation therapies designed to harness the body\u2019s natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including ARV-102, targeting LRRK2 for neurodegenerative disorders; ARV-393, targeting BCL6 for relapsed\/refractory non-Hodgkin Lymphoma; ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic and colorectal cancers; and vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+\/HER2- breast cancer. Arvinas is headquartered in New Haven, Connecticut. For more information about Arvinas, visit www.arvinas.com and connect on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wcO3263SriKwBF4UsYn611LUVxzeEqnXDhczDI6rwhKibxQrNUY3LOAOL08XEsEacX_UFl09WY1M0E2JlfI97XJWA0MaQ53POLiAVsRcR2s=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HJVHxZTwMZe_jiNHARQ_ZYuWKKcIneXqD6ZPgSa7LyNSD_R0ucyswS9XDhykz_BViAqRkeRgWJRwkJvsKiHu0g==\" rel=\"nofollow\" target=\"_blank\">X<\/a>.<\/p>\n<p align=\"left\">\n        <strong>Contacts<\/strong><br \/>\n        <br \/>\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Jeff Boyle<br \/>+1 (347) 247-5089<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qaOJl0euPiwyOsgp1tfTggrDSD1UPFkw4d01rySOarXgoMfM6QU3mzIyuX5nHKo_dOFQVkNjlZ6JBbS0xXQCQGhke47AXUBm91qskB0AuiL4WLwauP_xXgL7bOI-V4Eul-XkcCeZKA1MWU3FPCllaa5zJ7Ffi5DFUmWyfNJSjoPFy5XZ1oKMiXQp5widPp7q9UsBaen_eWB1QfWJLmSPddJga04tQwqj1I5H5vAD9Sxt0tH0nYKKaoPTUe-6FhuaiBpQ-hhwXkYCr0gO5ptVGcf8g4G9C21QVxKuP7YOG-nWHj1bvRH9XNzcZWrbnw1p72rPU7wYo4MOeZoomV46Y0qGfAHL5xHMAkpoVgA2Yabq_byIuS3FTXNOcN_wsq0Ge6OhR2sB8GgEqjKaeifSI6sVw7MwGVwgZGNuQjVWyAQJuxnsg2bW8xmlrlDy25H0b-B35mxH8-_edOt1FiAsAAIo-6vHlaOZgXmqRSZTbV4HNrM_eefnYU70sF1qwEMapNnS-AY0k2WtDrM7IAY8f60W-qRebA-_V7h7I2dI9eS-RbBxugdle-OgJBj_bYjAW0oyk_A7TU1snyTOnSvHqWSDAMdUpSQKzFZ42IvyA1OFRGiWUru--oFTFuT1-h4avqu0OAgihzjv_yxeNxENYfzW80CsS0JQlA7mZdsPhcRpQ1UikCmbhoHve3BNbAKgv982bOmQKHEfQjjA3HKdHsN9fgAk8QIqiVVzWYzTmdeAzOE-6ehqCxjHDh3xKD4xUWy6p0UXbZRyrL7rPzM8vqpQOMOFqgore7PH7EVWFnhUw0t2f7i0HJ8mSQmnxqjQX629wKq7UFNvt7Yg2PkLkvik9Bw9zGb3EtRD852Z-iR8JBc2Gz36d4sPz_eCQ7gsQ2LJ55NfXzHd725oPWGh9A8eT_W7bChh3oNpoMmViAxMxE58uxtKgJi4rvVnw3_5GyUv7RwlYLKOCe_0J0FvdavUFrh1m5G3fEBIERFXDxC1kmE8Agn5s_gnvt5klyFH8q7jdOjngBl-DFvRElKUwOAZd2e5kG0tekw91BrgJk1aCRXMkgvrdCub9TPIPAnGsSWWCB5_hcn8PiZPBSO2LVPUmpMh28NC5rcThABaV0QTURq6a4HYcXiv3WFQueYyclHGJk66QnN2rOLnLXxUCwrsgKVsk17HEdlybgAGzN1kZxyCo8a0VwjSyORx63Bo\" rel=\"nofollow\" target=\"_blank\"><strong>Jeff.Boyle@arvinas.com<\/strong><\/a><\/p>\n<p align=\"left\">\n        <strong>Media:<\/strong><br \/>\n        <br \/>Kirsten Owens<br \/>+1 (203) 584-0307<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VfqX_Q7pX9WOhGaOtr2GPYqcseaHqVF_ELfpLw18wPGQtmylDSodp_SKyZAz_xdvEgpSUaVC0RtoyBEjgYh2Xqd1DSL-GBZe45adlXptFUihERsQ6pNHozkAqNmytcjuN_fEaBITSD11vkfRJCEbF3MWpGkbzHLIOMQkqnDUvcPPvYZj_D3cSFjXZGi7xgYErl0cFSKbGRCN2Wcgsdg7qWLDeGfCVPGDXj57PUKhvFumrtEX1h3VJz5qccV0o1H4MMsyczhhWznY2JR_tnBn8dGMyYeYZvRjku0lUF3I6KAQH3WXiDkmI6_cP-rBQIeU_m1j-m7ggEOVCXBvtG_FQEso6aV0ktKZJfVpZYMx_skIxK-EDBS9bWjnwzzSgPVt54Jv-jsYwfbFTXSQ9ZQtzKIRL0pUKiYFrl8Xt5ESVPZ1xR0d_AmWiQHzn6hzf50Ok1d3ZJaxOF387YFzrLpBfdsSPrMApuQ4gmR6ATftAGYg60o17WJupoO7K9knOlbF_nYFkti0hOiB1Sd1ZGVcz-AfuECjj9fuHix-G04PAvlH1vuvk514CwvOjn1YVlgxPaNbQ3HW65NjxRCmOMeIRk1GjVCXqDggUWKbbMxskv5tYn7roB8QTqo8Qtdn-7XsC4rqk2FReA6JNlAmwoZUkMmx27d1HpMkDtcyFG6m3vnKLbgIwevVCCegJu6xplH3a0Duq3JnRLs1xVwoPSdmWTLYvBE7bs60kRiHLCCFJPs4iOGwC1X8aEqyGLf1Sco2tWsPaEOgoYGphkhT3ZqI4PwWBS5WRSu_cPsUYz6FjjQ=\" rel=\"nofollow\" target=\"_blank\"><strong>Kirsten.Owens@arvinas.com<\/strong><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjM5OSM3MjkzMDk2IzIxMjIwNzY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YTJhY2ViODMtYjkxMy00ZGQyLTgyYmUtYWJlOGJkMTYyOTRkLTExMzM2NDctMjAyNS0xMS0yNi1lbg==\/tiny\/Arvinas-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW HAVEN, Conn., Nov. 26, 2025 (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Noah Berkowitz, M.D., Ph.D., Chief Medical Officer, and Andrew Saik, Chief Financial Officer, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4 at 11:00 a.m. ET in New York. A live audio webcast of the presentation will be available\u00a0here\u00a0and on the Events and Presentations section of the Company\u2019s website. About\u00a0Arvinas Arvinas (Nasdaq: ARVN) is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. Through its PROTAC (PROteolysis TArgeting Chimera) protein degrader platform, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-913958","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW HAVEN, Conn., Nov. 26, 2025 (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Noah Berkowitz, M.D., Ph.D., Chief Medical Officer, and Andrew Saik, Chief Financial Officer, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4 at 11:00 a.m. ET in New York. A live audio webcast of the presentation will be available\u00a0here\u00a0and on the Events and Presentations section of the Company\u2019s website. About\u00a0Arvinas Arvinas (Nasdaq: ARVN) is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. Through its PROTAC (PROteolysis TArgeting Chimera) protein degrader platform, &hellip; Continue reading &quot;Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-26T12:06:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjM5OSM3MjkzMDk2IzIxMjIwNzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference\",\"datePublished\":\"2025-11-26T12:06:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\\\/\"},\"wordCount\":257,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjM5OSM3MjkzMDk2IzIxMjIwNzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\\\/\",\"name\":\"Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjM5OSM3MjkzMDk2IzIxMjIwNzY=\",\"datePublished\":\"2025-11-26T12:06:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjM5OSM3MjkzMDk2IzIxMjIwNzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjM5OSM3MjkzMDk2IzIxMjIwNzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk","og_description":"NEW HAVEN, Conn., Nov. 26, 2025 (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Noah Berkowitz, M.D., Ph.D., Chief Medical Officer, and Andrew Saik, Chief Financial Officer, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4 at 11:00 a.m. ET in New York. A live audio webcast of the presentation will be available\u00a0here\u00a0and on the Events and Presentations section of the Company\u2019s website. About\u00a0Arvinas Arvinas (Nasdaq: ARVN) is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. Through its PROTAC (PROteolysis TArgeting Chimera) protein degrader platform, &hellip; Continue reading \"Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-26T12:06:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjM5OSM3MjkzMDk2IzIxMjIwNzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference","datePublished":"2025-11-26T12:06:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/"},"wordCount":257,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjM5OSM3MjkzMDk2IzIxMjIwNzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/","name":"Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjM5OSM3MjkzMDk2IzIxMjIwNzY=","datePublished":"2025-11-26T12:06:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjM5OSM3MjkzMDk2IzIxMjIwNzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjM5OSM3MjkzMDk2IzIxMjIwNzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-present-at-piper-sandler-37th-annual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/913958","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=913958"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/913958\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=913958"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=913958"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=913958"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}